세계의 박막 의약품 제조 시장 규모 조사 : 제품별, 적응증별, 유통 채널별, 지역별 예측(2022-2032년)

The Global Thin Film Drug Manufacturing Market was valued at USD 6.4 billion in 2023 and is projected to grow with a compound annual growth rate (CAGR) of 9.0% from 2024 to 2032. Thin film drug manufacturing involves the design and production of thin films containing biochemical elements for pharmaceutical purposes, which can be administered sublingually, orally, or via transdermal methods. These advanced drug delivery systems offer precise dosage, improved patient compliance, ease of administration, and rapid onset of biological effects, making them especially beneficial for children and the elderly.

The increasing global elderly population, driven by improvements in healthcare facilities and a decline in birth rates, is a prominent contributor to the growth of the thin film drug manufacturing market. Thin film drug delivery systems are particularly advantageous for the elderly, as they reduce the risk of choking, ease swallowing difficulties, and improve the overall administration of drugs. The rise in investment in drug delivery technologies is another significant factor augmenting the market size. The surge in integration of nanotechnology in drug delivery, targeted drug deliveries, and personalized medicine for improved patient care and quality of life are gaining traction. Leading players in the global market are innovating to provide cost-effective and convenient formulations, further driving market growth.

The key regions considered for the Global Thin Film Drug Manufacturing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. North America is the dominating region in the Global Thin Film Drug Manufacturing Market. This dominance is primarily attributed to the region's advanced healthcare infrastructure, significant investment in research and development, and the presence of major pharmaceutical companies. The United States, in particular, leads in innovation and adoption of advanced drug delivery technologies, including thin film drug manufacturing. Additionally, favorable regulatory policies and substantial funding from both government and private sectors support the development and commercialization of thin film drug products. Moreover, Asia Pacific is projected to register fastest growth during to forecast period owing to rising disease prevalence, rising government initiatives for drug manufacturing in the region.

Major market player included in this report are:

• Pfizer, Inc.
• Novartis AG
• Wolters Kluwer
• Solvay
• AbbVie
• Sumitomo Pharma Co., Ltd
• IntelGenx Corp.
• NAL Pharma
• ZIM Laboratories Limited
• Indivior PLC
• MonoSol
• GSK (GlaxoSmithKline plc)
• Cure Pharmaceutical Holding Corp.
• Sumitomo Dainippon Pharma Co., Ltd.
• Allergan plc

The detailed segments and sub-segment of the market are explained below:

By Product

• Oral Thin Film
• Sublingual Film
• Fully Dissolving Dental/Buccal Film
• Transdermal Thin Film
• Others

By Disease Indication

• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-commerce

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE (Rest of Europe)
• Asia Pacific
• China
• India
• Japan
• Australia
• RoAPAC (Rest of Asia Pacific)
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA (Rest of Middle East & Africa)

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Thin Film Drug Manufacturing Market Executive Summary

• 1.1. Global Thin Film Drug Manufacturing Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Disease Indication
  • 1.3.3. By Distribution Channel
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Thin Film Drug Manufacturing Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Thin Film Drug Manufacturing Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Advancements in Drug Delivery Technologies
  • 3.1.2. Increase in Geriatric Population
  • 3.1.3. Rising Investments in Drug Delivery Technologies
• 3.2. Market Challenges
  • 3.2.1. High Cost of Development and Manufacturing
  • 3.2.2. Regulatory Challenges
• 3.3. Market Opportunities
  • 3.3.1. Integration of Nanotechnology
  • 3.3.2. Growth in Personalized Medicine

Chapter 4. Global Thin Film Drug Manufacturing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Thin Film Drug Manufacturing Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Thin Film Drug Manufacturing Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Oral Thin Film
  • 5.2.2. Sublingual Film
  • 5.2.3. Fully Dissolving Dental/Buccal Film
  • 5.2.4. Transdermal Thin Film
  • 5.2.5. Others (Ocular Thin Film, etc.)

Chapter 6. Global Thin Film Drug Manufacturing Market Size & Forecasts by Disease Indication 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Thin Film Drug Manufacturing Market: Disease Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Schizophrenia
  • 6.2.2. Migraine
  • 6.2.3. Opioid Dependence
  • 6.2.4. Nausea & Vomiting
  • 6.2.5. Others

Chapter 7. Global Thin Film Drug Manufacturing Market Size & Forecasts by Distribution Channel 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Thin Film Drug Manufacturing Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Hospital Pharmacies
  • 7.2.2. Drug Stores
  • 7.2.3. Retail Pharmacies
  • 7.2.4. E-commerce

Chapter 8. Global Thin Film Drug Manufacturing Market Size & Forecasts by Region 2022-2032

• 8.1. North America Thin Film Drug Manufacturing Market
  • 8.1.1. U.S. Thin Film Drug Manufacturing Market
    • 8.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Disease Indication breakdown size & forecasts, 2022-2032
    • 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Thin Film Drug Manufacturing Market
• 8.2. Europe Thin Film Drug Manufacturing Market
  • 8.2.1. U.K. Thin Film Drug Manufacturing Market
  • 8.2.2. Germany Thin Film Drug Manufacturing Market
  • 8.2.3. France Thin Film Drug Manufacturing Market
  • 8.2.4. Spain Thin Film Drug Manufacturing Market
  • 8.2.5. Italy Thin Film Drug Manufacturing Market
  • 8.2.6. Rest of Europe Thin Film Drug Manufacturing Market
• 8.3. Asia-Pacific Thin Film Drug Manufacturing Market
  • 8.3.1. China Thin Film Drug Manufacturing Market
  • 8.3.2. India Thin Film Drug Manufacturing Market
  • 8.3.3. Japan Thin Film Drug Manufacturing Market
  • 8.3.4. Australia & New Zealand Thin Film Drug Manufacturing Market
  • 8.3.5. Rest of Asia Pacific Thin Film Drug Manufacturing Market
• 8.4. Latin America Thin Film Drug Manufacturing Market
  • 8.4.1. Brazil Thin Film Drug Manufacturing Market
  • 8.4.2. Mexico Thin Film Drug Manufacturing Market
  • 8.4.3. Rest of Latin America Thin Film Drug Manufacturing Market
• 8.5. Middle East & Africa Thin Film Drug Manufacturing Market
  • 8.5.1. Saudi Arabia Thin Film Drug Manufacturing Market
  • 8.5.3. South Africa Thin Film Drug Manufacturing Market
  • 8.5.4. Rest of Middle East & Africa Thin Film Drug Manufacturing Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Pfizer, Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Novartis AG
  • 9.3.3. Wolters Kluwer
  • 9.3.4. Solvay
  • 9.3.5. AbbVie
  • 9.3.6. Sumitomo Pharma Co., Ltd
  • 9.3.7. IntelGenx Corp.
  • 9.3.8. NAL Pharma
  • 9.3.9. ZIM Laboratories Limited
  • 9.3.10. Indivior PLC
  • 9.3.11. MonoSol
  • 9.3.12. GSK (GlaxoSmithKline plc)
  • 9.3.13. Cure Pharmaceutical Holding Corp.
  • 9.3.14. Sumitomo Dainippon Pharma Co., Ltd.
  • 9.3.15. Allergan plc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes